| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0,0 € | 0,0 € | 0,0 € | — | ||||||
| Gross margin | 35,5 k € | -48.7% | 69,2 k € | +26.7% | 54,6 k € | +102.8% | 26,9 k € | -35.0% | 41,4 k € | +14.7% | 36,1 k € | |
| EBITDA | 34,4 k € | -47.5% | 65,5 k € | +21.3% | 54,0 k € | +104.7% | 26,4 k € | -35.8% | 41,1 k € | +16.0% | 35,4 k € | |
| Operating profit | 73,0 k € | +1318.0% | 5,1 k € | -89.3% | 48,1 k € | +112.8% | 22,6 k € | -44.5% | 40,7 k € | +18.5% | 34,3 k € | |
| Profit/loss | 12,5 k € | +361.9% | 2,7 k € | -92.2% | 34,5 k € | +105.5% | 16,8 k € | -42.3% | 29,1 k € | -3.0% | 30,0 k € | |
| Equity | 67,5 k € | +7.2% | 63,0 k € | -7.7% | 68,3 k € | +51.8% | 45,0 k € | +24.3% | 36,2 k € | +140.6% | 15,0 k € | |
| Total assets | 92,6 k € | -35.5% | 143,7 k € | +34.4% | 106,9 k € | +34.6% | 79,4 k € | -16.9% | 95,6 k € | +166.9% | 35,8 k € | |
| Cash | 35,9 k € | -58.8% | 86,9 k € | +7.2% | 81,1 k € | +56.3% | 51,9 k € | +386.8% | 10,7 k € | -64.5% | 30,0 k € | |
| Debts | 25,1 k € | -13.6% | 29,0 k € | -24.8% | 38,6 k € | +12.0% | 34,4 k € | -42.1% | 59,4 k € | +186.0% | 20,8 k € | |
Private limited company profitable and well capitalised. Cash position declining (-58.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Injection Test is a Private limited company incorporated in 2019. Its main activity is: Manufacture of plastics in primary forms. Its registered office is in Oupeye.
Source: Belgian Official Gazette
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.